Radiation guidelines for gliomas

被引：4

作者：

Antoni, D. ^{[1
]}

Feuvret, L. ^{[2
]}

Biau, J. ^{[3
]}

Robert, C. ^{[4
]}

Mazeron, J-J ^{[2
]}

Noel, G. ^{[1
]}

机构：

[1] Inst Cancerol Strasbourg Europe ICANS, Serv Radiotherapie, 17 Rue Albert Calmette, F-67200 Strasbourg, France

[2] CHU Pitie Salpetriere, AP HP, Serv Radiotherapie, 47-83 Blvd Hop, F-75013 Paris, France

[3] Unicancer, Dept Univ Radiotherapie, Ctr Jean Perrin, 58 Rue Montalembert,BP 392, F-63011 Clermont Ferrand 01, France

[4] Inst Cancerol Gustave Roussy, Dept Radiotherapie, 39 Rue Camille Desmoulin, F-94800 Villejuif, France

来源：

CANCER RADIOTHERAPIE | 2022年 / 26卷 / 1-2期

关键词：

Recommendations; Glioblastoma; Anaplastic glioma; Diffuse glioma; Biomarkers; Radiation therapy; French society for radiation oncology; LOW-GRADE GLIOMA; INTENSITY-MODULATED RADIOTHERAPY; NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-III TRIAL; QUALITY-OF-LIFE; PROGNOSTIC-FACTOR ANALYSIS; WHOLE-BRAIN RADIOTHERAPY; STEM-CELL COMPARTMENT; ANAPLASTIC OLIGODENDROGLIOMA; EUROPEAN ORGANIZATION;

D O I：

10.1016/j.canrad.2021.08.006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Gliomas are the most frequent primary brain tumour. The proximity of organs at risk, the infiltrating nature, and the radioresistance of gliomas have to be taken into account in the choice of prescribed dose and technique of radiotherapy. The management of glioma patients is based on clinical factors (age, KPS) and tumour characteristics (histology, molecular biology, tumour location), and strongly depends on available and associated treatments, such as surgery, radiation therapy, and chemotherapy. The knowledge of molecular biomarkers is currently essential, they are increasingly evolving as additional factors that facilitate diagnostics and therapeutic decision-making. We present the update of the recommendations of the French society for radiation oncology on the indications and the technical procedures for performing radiation therapy in patients with gliomas. (C) 2021 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：116 / 128

页数：13

共 113 条

[11] Brada M, 2014, AM SOC CLIN ONCOL ED, P94, DOI [10.14694/EdBookAM.2014.34.e89, DOI 10.14694/EDBOOKAM.2014.34.E89]
[12] Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001
Brown, Paul D.
Gondi, Vinai
Pugh, Stephanie
Tome, Wolfgang A.
Wefel, Jeffrey S.
Armstrong, Terri S.
Bovi, Joseph A.
Robinson, Cliff
Konski, Andre
Khuntia, Deepak
Grosshans, David
Benzinger, Tammie L. S.
Bruner, Deborah
Gilbert, Mark R.
Roberge, David
Kundapur, Vijayananda
Devisetty, Kiran
Shah, Sunjay
Usuki, Kenneth
Anderson, Bethany Marie
Stea, Baldassarre
Yoon, Harold
Li, Jing
Laack, Nadia N.
Kruser, Tim J.
Chmura, Steven J.
Shi, Wenyin
Deshmukh, Snehal
Mehta, Minesh P.
Kachnic, Lisa A.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (10) : 1019 - +
[13] Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Buckner, Jan C.
Shaw, Edward G.
Pugh, Stephanie L.
Chakravarti, Arnab
Gilbert, Mark R.
Barger, Geoffrey R.
Coons, Stephen
Ricci, Peter
Bullard, Dennis
Brown, Paul D.
Stelzer, Keith
Brachman, David
Suh, John H.
Schultz, Christopher J.
Bahary, Jean-Paul
Fisher, Barbara J.
Kim, Harold
Murtha, Albert D.
Bell, Erica H.
Won, Minhee
Mehta, Minesh P.
Curran, Walter J., Jr.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (14) : 1344 - 1355
[14] Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
Cairncross, Gregory
Berkey, Brian
Shaw, Edward
Jenkins, Robert
Scheithauer, Bernd
Brachman, David
Buckner, Jan
Fink, Karen
Souhami, Luis
Laperierre, Normand
Mehta, Minesh
Curran, Walter
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2707 - 2714
[15] Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
Cairncross, Gregory
Wang, Meihua
Shaw, Edward
Jenkins, Robert
Brachman, David
Buckner, Jan
Fink, Karen
Souhami, Luis
Laperriere, Normand
Curran, Walter
Mehta, Minesh
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (03) : 337 - 343
[16] Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
Cairncross, J. Gregory
Wang, Meihua
Jenkins, Robert B.
Shaw, Edward G.
Giannini, Caterina
Brachman, David G.
Buckner, Jan C.
Fink, Karen L.
Souhami, Luis
Laperriere, Normand J.
Huse, Jason T.
Mehta, Minesh P.
Curran, Walter J., Jr.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (08) : 783 - +
[17] Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy
Chan, JL
Lee, SW
Fraass, BA
Normolle, DP
Greenberg, HS
Junck, LR
Gebarski, SS
Sandler, HM
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1635 - 1642
[18] Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma
Chang, Eric L.
Akyurek, Serap
Avalos, Tedde
Rebueno, Neal
Spicer, Chris
Garcia, John
Famiglietti, Robin
Allen, Pamela K.
Chao, K. S. Clifford
Mahajan, Anita
Woo, Shiao Y.
Maor, Moshe H.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01): : 144 - 150
[19] Chargari C, 2016, CANCER RADIOTHER, V20, pS1
[20] SIMULTANEOUS INTEGRATED BOOST INTENSITY-MODULATED RADIOTHERAPY IN PATIENTS WITH HIGH-GRADE GLIOMAS
Cho, Kwan Ho
Kim, Joo-Young
Lee, Seung Hoon
Yoo, Heon
Shin, Sang Hoon
Moon, Sung Ho
Kim, Tae Hyun
Shin, Kyung Hwan
Yoon, Myonggeun
Lee, Doo-Hyun
Pyo, Hong Ryull
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (02): : 390 - 397

← 1 2 3 4 5 6 7 8 9 10 →